Failure of physostigmine in intoxications with tricyclic antidepressants in rats.
In experiments on rats there is a moderate antagonistic effect of physostigmine against intoxications with the tricyclic antidepressants (TAD) clomipramine, desipramine and imipramine, respectively. During the first hours after TAD intoxication the survival rate is higher in physostigmine treated rats. Especially after relatively low doses of TAD the lethality seems to be reduced by physostigmine treatment. However, at the end of the observation period (96 h) the lethality after TAD is equal with and without physostigmine treatment. The effectivity of physostigmine does not depend on the mode of administration: repeated administration and intravenous infusion are not more effective than a single injection of physostigmine. The influence of TAD on heart rate and respiratory rate was not abolished by physostigmine salicylate. Intoxications with high doses of physostigmine were antagonized by atropine; on the other hand there are no signs for an antagonistic effect of desipramine against physostigmine intoxication, that means their anticipated anticholinergic properties could not be proved.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000633:toxicity*; D001285:Atropine / Q000494:pharmacology; D002997:Clomipramine / Q000633:toxicity; D003891:Desipramine / Q000633:toxicity; D004347:Drug Interactions; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007099:Imipramine / Q000633:toxicity; D007928:Lethal Dose 50; D010830:Physostigmine / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D012119:Respiration / Q000187:drug effects; D013997:Time Factors
D000929:Antidepressive Agents, Tricyclic; D001285:Atropine; D010830:Physostigmine; D002997:Clomipramine; D007099:Imipramine; D003891:Desipramine